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Hydrogels are three dimensional, crosslinked networks of hydrophilic polymers 
swollen with a large amount of water or biological fluids. They can be combined with 
granules of ceramic-based synthetic bone substitutes (SBSs) aiming to stabilize them 
into bone defects and to obtain injectable formulations. Our research group has been 
characterizing a fully resorbable and injectable dextrin-based hydrogel (HG) which was 
intended to perform as a multifunctional platform, enabling the combination with 
stem cells and other bioactive agents, during clinical procedures [1-3]. In a 
subcutaneous assay, the HG was able to incorporate and stabilize ceramic granules 
(250-500 um) in the implant site, demonstrating its potential as an injectable carrier 
and stabilizer of SBSs [3].  
The development of biomaterials for medical applications includes extensive 
preclinical testing in order to demonstrate their biocompatibility, safety and efficacy. 
Thus, in this work, the subacute systemic toxicity of the HG was assessed, as well as, 
the bone histocompatibility and skin sensitization, using rodent models. The obtained 
results revealed that the HG did not induce any significant systemic toxic effect or skin 
reaction, neither impaired the bone repair/regeneration process, showing its 
potential for bone tissue engineering field. 
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